OSA patients not treated with PAP - evolution 5 years ahead according to Baveno classification

M. Serino (Porto, Portugal), C. Cardoso (Porto, Portugal), R. Cordeiro (Torres Vedras, Portugal), J. Ferra (Lisboa, Portugal), F. Aguiar (Braga, Portugal), D. Rodrigues (Porto, Portugal), M. Redondo (Porto, Portugal), M. Van Zeller (Porto, Portugal), M. Drummond (Porto, Portugal)

Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Serino (Porto, Portugal), C. Cardoso (Porto, Portugal), R. Cordeiro (Torres Vedras, Portugal), J. Ferra (Lisboa, Portugal), F. Aguiar (Braga, Portugal), D. Rodrigues (Porto, Portugal), M. Redondo (Porto, Portugal), M. Van Zeller (Porto, Portugal), M. Drummond (Porto, Portugal). OSA patients not treated with PAP - evolution 5 years ahead according to Baveno classification. 2486

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013

2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Symptomatic assessment in COPD GOLD 2011 classification - mMRC/CAT agreement
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Obstructive sleep-disordered breathing in children 2-18 years old: indications for treatment, stepwise treatment approach and recognition and management of persistent disease
Source: International Congress 2015 – Obstructive sleep apnoea in adults and children
Year: 2015



The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015

What clinical features underlying GINA step 1-4 drive the level of treatment in patients with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 57s
Year: 2001

Heterogeneity of group D in the new GOLD classification of COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Prediction of the clinical course of COPD using the old and the new GOLD classification
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Chronic obstructive pulmonary disease in 55 years old women from Germany according to GOLD stages
Source: Eur Respir J 2004; 24: Suppl. 48, 359s
Year: 2004

The current ERS, BTS, ATS and GOLD classification criteria underestimate the impact of COPD on patients
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002

Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003

High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


More than half of patients with COPD in Poland are still smoking, only one third is treated according to GOLD recommendations – Results from PulmoScreen study
Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD
Year: 2010

Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study)
Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015
Year: 2017